Pharmacology

Imatinib Five Years Later

Fed Pract. 2007 March;24(3):52
PDF Download

 

Recommended Reading

Hypothyroidism with Sunitnib
Federal Practitioner
IFN for Renal Cell Cancer: Impact of Dose
Federal Practitioner
When to Screen for Postpolypectomy Polyps
Federal Practitioner
VA Study Questions PSA Screening
Federal Practitioner
Cancer's Long-Term Effects
Federal Practitioner
Sunitinib: At What Dose Is Toxicity Manageable?
Federal Practitioner
Failure to Disclose Prognosis
Federal Practitioner
When Substance Abuse Interferes with Cancer Treatment
Federal Practitioner
Friends, Family, and IL-6
Federal Practitioner
Treating Cancer During Pregnancy
Federal Practitioner